ZEOX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZEOX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-23), Zeo ScientifiX's current share price is $0.97. Zeo ScientifiX's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was $0.88. Zeo ScientifiX's Cyclically Adjusted PS Ratio for today is 1.10.
The historical rank and industry rank for Zeo ScientifiX's Cyclically Adjusted PS Ratio or its related term are showing as below:
During the past years, Zeo ScientifiX's highest Cyclically Adjusted PS Ratio was 31.06. The lowest was 1.15. And the median was 4.56.
ZEOX's Cyclically Adjusted PS Ratio is ranked better thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Zeo ScientifiX's adjusted revenue per share data for the three months ended in Jan. 2024 was $0.001. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.88 for the trailing ten years ended in Jan. 2024.
The historical data trend for Zeo ScientifiX's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
Cyclically Adjusted PS Ratio | Get a 7-Day Free Trial | 4.02 | 2.38 | 3.98 | 2.01 | 1.45 |
For the Biotechnology subindustry, Zeo ScientifiX's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Cyclically Adjusted PS Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
Zeo ScientifiX's Cyclically Adjusted PS Ratio for today is calculated as
Cyclically Adjusted PS Ratio | = | Share Price | / | Cyclically Adjusted Revenue per Share |
= | 0.97 | / | 0.88 | |
= | 1.10 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 is calculated as:
For example, Zeo ScientifiX's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Jan. 2024 (Change) | * | Current CPI (Jan. 2024) |
= | 0.001 | / | 130.1244 | * | 130.1244 | |
= | 0.001 |
Current CPI (Jan. 2024) = 130.1244.
Zeo ScientifiX Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201404 | 0.024 | 100.023 | 0.031 |
201407 | 0.028 | 100.520 | 0.036 |
201410 | -0.060 | 100.176 | -0.078 |
201501 | 0.000 | 98.604 | 0.000 |
201504 | 0.000 | 99.824 | 0.000 |
201507 | 0.042 | 100.691 | 0.054 |
201510 | 0.234 | 100.346 | 0.303 |
201601 | 0.125 | 99.957 | 0.163 |
201604 | 0.134 | 100.947 | 0.173 |
201607 | 0.050 | 101.524 | 0.064 |
201610 | 0.063 | 101.988 | 0.080 |
201701 | 0.002 | 102.456 | 0.003 |
201704 | 0.261 | 103.167 | 0.329 |
201707 | 0.300 | 103.278 | 0.378 |
201710 | 0.472 | 104.070 | 0.590 |
201801 | 0.748 | 104.578 | 0.931 |
201804 | 0.144 | 105.708 | 0.177 |
201807 | 0.102 | 106.324 | 0.125 |
201810 | 0.114 | 106.695 | 0.139 |
201901 | 0.080 | 106.200 | 0.098 |
201904 | 0.160 | 107.818 | 0.193 |
201907 | 0.243 | 108.250 | 0.292 |
201910 | 0.233 | 108.577 | 0.279 |
202001 | 0.276 | 108.841 | 0.330 |
202004 | 0.218 | 108.173 | 0.262 |
202007 | 0.209 | 109.318 | 0.249 |
202010 | 0.222 | 109.861 | 0.263 |
202101 | 0.283 | 110.364 | 0.334 |
202104 | 0.227 | 112.673 | 0.262 |
202107 | 0.248 | 115.183 | 0.280 |
202110 | 0.298 | 116.696 | 0.332 |
202201 | 0.302 | 118.619 | 0.331 |
202204 | 0.322 | 121.978 | 0.344 |
202207 | 0.315 | 125.002 | 0.328 |
202210 | 0.195 | 125.734 | 0.202 |
202301 | 0.001 | 126.223 | 0.001 |
202304 | 0.116 | 127.992 | 0.118 |
202307 | 0.172 | 128.974 | 0.174 |
202310 | 0.195 | 129.810 | 0.195 |
202401 | 0.001 | 130.124 | 0.001 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
Thank you for viewing the detailed overview of Zeo ScientifiX's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Skycrest Holdings, Llc | 10 percent owner | 1930 HARRISON STREET, SUITE 204, HOLLYWOOD FL 33020 |
Harry L. Leider | director, officer: CEO and Director | C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116 |
Howard Lawrence Golub | officer: Executive Vice President & CSO | 23648 SEPTEMBER SUN SQ, ASHBURN VA 20148 |
Matthew Phillip Sinnreich | officer: COO and Acting CEO | 4045 SHERIDAN AVENUE, SUITE 239, MIAMI BEACH FL 33139 |
Steven Jerry Glauser | director | 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131 |
Leathem S Stearn | director | 2306 BAY DRIVE, POMPANO BEACH FL 33062 |
Charles Luther Bretz | director | 58 N. CHICAGO ST, 2ND FLOOR, JOLIET IL 60432 |
Bhupendra Kumar Modi | director | 6 MARINA BOULEVARD, #63-18, THE SALE @ MARINA BAY U0 018985 |
Gurvinder Pal Singh | director | E - 128, FIRST FLOOR, GREATER KAILASH - II, NEW DELHI K7 110048 |
John F Chiste | director | |
Ryan C Likes | officer: Chief Operating Officer | 1116 MEADOWBROOK AVE., LOS ANGELES CA 90019 |
Greyt Ventures, Llc | 10 percent owner | GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180 |
Wendy Grey | 10 percent owner | GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180 |
Ian T Bothwell | 10 percent owner, officer: Chief Financial Officer | 77 530 ENFIELD LANE, BLDG D, PALM DESERT CA 92211 |
Albert Mitrani | director, officer: Chief Executive Officer | 4045 SHERIDAN AVE., SUITE 239, MIAMI BEACH FL 33140 |
From GuruFocus
By PRNewswire PRNewswire • 11-09-2021
By ACCESSWIRE ACCESSWIRE • 08-27-2022
By Marketwired Marketwired • 05-05-2020
By ACCESSWIRE ACCESSWIRE • 07-26-2022
By ACCESSWIRE • 07-26-2023
By Marketwired Marketwired • 10-20-2020
By ACCESSWIRE • 06-29-2023
By Marketwired Marketwired • 08-18-2020
By ACCESSWIRE ACCESSWIRE • 11-22-2022
By Marketwired Marketwired • 08-13-2020